PMSEIC tackles climate change and water issues

The Prime Minister’s Science, Engineering and Innovation Council (PMSEIC), which met in Canberra on 22 June, heard presentations of reports by two working groups on environmental themes - Climate Change in Australia and Water for Our Cities.

The report, Climate Change in Australia: Regional Impacts and Adaptation, was presented by three of its authors: Professor Gerard Sutton, Chair of Universities Australia; Dr Chris Mitchell, Research Theme Leader, Climate, Weather and Ocean Prediction with CSIRO; and Dr Deborah Rathjen, CEO and Managing Director of Bionomics Limited. It highlighted the susceptibility of Australia’s economy to climate change and the need for and benefits of adaptation.

The report focuses on six sectors: cities and coastal communities, water, health, agriculture, infrastructure and natural systems.

It recommends that Australian governments should give priority to developing adaptation plans for Australia’s major cities and urban complexes, the Murray-Darling Basin; iconic biodiversity hot-spots; and communities with lower capacity to adapt.

The report also recommends that a national summit should be held to develop a blueprint for adaptation to climate change, and that climate change should become a National Research Priority and impediments to multidisciplinary collaborative programmes of research relevant to climate change adaptation research should be removed.

Other recommendations included an assessment of the socioeconomic impacts and consequences of climate change and the benefits of adaptation; and communication of practical adaptations and encouraging stakeholders to participate in adaptation research.

The second working group report, Water for our Cities – Building resilience in a climate of uncertainty, was presented by Professor Tom Spurling, President of the Federation of Australian Scientific and Technological Societies (FASTS); Dr John Marsden, Director of Marsden Jacobs Associates; and Professor Tony Priestly of the CRC for Water Quality and Treatment.

The report assesses the current water supply crisis facing Australia’s cities and the range of options for addressing it.

Recommendations include:

• that the Australian Government should work with the States and Territories to apply a comprehensive risk based planning and evaluation framework to determine, for each town and city, the optimum portfolio of water supply options, and mandate the use of the framework in any Commonwealth funding programme;
• that, through the National Water Initiative and the COAG process, the Australian Government should explore the adoption of efficient urban tariff structures including developer charges and explore tradeable urban water and other entitlements;
• that governments should undertake nationally coordinated social research to strengthen their understanding of community aspirations, values and fears relating to urban water supply;
• that the Australian Government strengthen investment in targeted research on urban water issues, particularly in: improved membrane separation technologies; better monitoring and control technologies; closure of key data gaps to allow proper evaluation of supply options and their impact; and decision analytic frameworks tailored to the selection and operation of a risk efficient portfolio of water supply options;
• that the Australian Government establish a network linking innovative demonstration projects of alternative water supply systems and use the network to provide comparative data and to facilitate research and training, technology transfer and community education;
• the Australian Government encourage enrolment in relevant courses in science, engineering, public health, urban planning and architecture and advanced trade skills to fill the gaps in needed skills for innovative water supplies.
• that to remove barriers to the efficient implementation of non-traditional supply schemes the Australian Government work with the States and Territories to reduce fragmentation and enhance communication between relevant regulatory authorities.
• that to encourage innovation the Australian Government in cooperation with the States and Territories establish a set of mandatory minimum standards for water efficiency in new appliances, homes, commercial and government premises and subdivision design.

Other agenda items of the PMSEIC meeting included a report by the Minister for Education, Science and Training, Julie Bishop, on follow up to the report Data for Science and Australia’s Science and Technology Priorities for Global Engagement which were tabled at the last meeting.

The working group presentations were followed by presentations from two early-career environmental scientists - Dr Ben McNeil and Dr Michael Storey. Dr McNeil is Senior Research Fellow, Climate Change Research Centre, UNSW. Dr Storey is Project Manager, Science and Technology, Sydney Water Corporation. Their presentations highlighted their respective career paths and fields of research.

The reports and presentations are available at here

Back to Headlines>>

Stocker appointed to chair CSIRO Board

The former Chief Executive Officer of CSIRO, Dr John Stocker, has been appointed as the new chair of the CSIRO Board.

Dr Stocker was CSIRO’s CEO from 1990 to 1995, and was Australia’s Chief Scientist from 1996 to 1999. He is currently the Chairman of Sigma Pharmaceuticals Limited, as well as a Director of Telstra Corporation, Circadian Technologies Limited and Nufarm Limited. He has also served on various Government scientific advisory bodies.

Two members of the CSIRO Board, Professor Suzanne Cory and Dr Terrence Cutler, have been reappointed.

Back to Headlines>>

New appointments to ANSTO Board

Two new appointments have been made to the ANSTO Board. They are Bill Scales and Professor Paul Greenfield.

Mr Scales is currently the Chancellor of Swinburne University of Technology and serves on several boards, including Chairman of the Port of Melbourne Corporation. His previous roles include executive positions at Telstra Corporation Ltd and Chairman of the Industry Commission.

Professor Greenfield is currently the Senior Deputy Vice-Chancellor of the University of Queensland, and also a director of several companies including UniQuest Pty Ltd, National ICT Australia Ltd and the Australian Institute of Commercialisation.

Back to Headlines>>

New cancer research centre for UNSW

A new cancer research centre is to be built at the University of New South Wales following an agreement by businessman and philanthropist Mr Frank Lowy and family who have agreed to donate $10 million towards the cost of the new building.

The $100 million plus facility, to be known as the Lowy Cancer Research Centre, will house up to 400 cancer researchers, from UNSW and Children’s Cancer Institute Australia (CCIA). It will be one of the largest dedicated cancer research centres in the Southern Hemisphere and Australia’s only fully integrated childhood and adult cancer research centre.

In addition to the Lowy gift and University resources, other funding has come from individual donors, trusts, foundations and grants awarded to CCIA by the NSW State Government ($18.3m), the Commonwealth Government ($13.3m), and most recently the Australian Cancer Research Foundation ($3.1m).

Construction of the building is expected to begin in October this year, with a scheduled completion date of late 2009. It will be constructed on the northern (Randwick) end of the UNSW campus.

Back to Headlines>>

CSIRO to develop government online services system

CSIRO ICT Centre has been commissioned to develop delivery models for the $42 million Australian Government Online Services Point (AGOSP) that will provide public internet access to Australian Government services.

The government portal will allow people to find information and carry out transactions with several agencies.

The CSIRO ICT Centre and the Australian Government Information Management Office (AGIMO) will collaborate on developing the delivery model. AGOSP will be developed over four years, with the first stage scheduled to begin operation in December 2008, and completion of the project by December 2010.

Director of the CSIRO ICT Centre, Dr Alex Zelinsky said that current service delivery models do not take into account the tasks a person is trying to accomplish or the context in which they are working.

“Australians are increasingly turning to online transactional services to conduct their day-to-day affairs. CSIRO’s goal is to contribute to developing e-services for Government that are easy to use, meet the real needs of people and ensure security and privacy,” Dr Zelinsky said.

Back to Headlines>>

National Institute for Complementary Medicine funded

The Commonwealth Government will provide $4 million to the University of Western Sydney to help establish a National Institute for Complementary Medicine.

The institute will develop national priorities for complementary medical research and will coordinate work on these priorities with other research bodies, with an emphasis on clinical trials and studies on herbal medicines.

The institute will also support postdoctoral training to ensure that the industry has the research personnel it needs to expand. It will also provide research findings to the medical community and general public.

The Commonwealth Government has also provided $5 million in grants through the National Health and Medical Research Council to investigate the use and effectiveness of complementary and alternative medicines.

Back to Headlines>>

Funding for Victorian-Israeli collaborations

Two projects have been financed through the Victoria-Israel Science and Technology R&D Fund (VISTECH), a three-year collaborative program to which Israel and Victoria are each providing US$1 million each year (AU$1.18 million).

One of new projects is the development and manufacture of an Acoustic Severe Asthma Monitor by Malvern-based company Pulmosonix and Israeli company Karmelsonix to provide non-invasive continuous monitoring of severe asthma patients.

The second grant will be used to develop and manufacture a urethral stent covered in a specially designed material embedded with drugs. Israeli company, Allium will manufacture the stent while Mulgrave-based company, Aortech Biomaterials, will develop the polymer, drug embedded material that covers the stent.

VISTECH funds up to 50 per cent of joint R&D costs up to $590,000 for Israeli-Victorian market-oriented projects in areas such as biotechnology environmental technologies, healthcare and advanced manufacturing.

Back to Headlines>>

Australian Synchrotron in MOU with CERN

The Victorian Government has signed Memorandum of Understanding (MOU) to promote scientific collaboration between the Australian Synchrotron and the European Organisation for Nuclear Research (CERN), located in Geneva, Switzerland.

This agreement with CERN will enable the Australian Synchrotron to benefit from the participation in common R&D related to technologies for accelerators, from staff exchanges and from the courses in advanced accelerator physics offered by CERN.

CERN does not have a synchrotron light source, but its facilities are at the forefront of global developments in accelerator science. It is currently completing the Large Hadron Collider, a machine 27 kilometres in circumference that will be used to study the kinds of reactions that occurred at the birth of the universe.

Back to Headlines>>

Life science awards attract researchers to NSW

The NSW Government has awarded Life Science Research Awards to three international scientists to assist them to set up research teams in the state.

The awards, announced in the first round of the $5 million program, have gone to:

• immune system expert Professor Wolfgang Weninger who was appointed to the Centenary Institute in Sydney in June;
• cognition and brain sciences expert Professor John Hodges who will be jointly hosted by the Prince of Wales Medical Research Institute and the University of NSW from November; and
• genomics expert Dr Ian Paulsen who will be based at Macquarie University from this month.

Applications for the second round of the Life Science Research Awards will be called this month.

Back to Headlines>>

Grants for international travel: International Science Linkages Programme – Science Academies Programme

                          

The Australian Academy of Science is inviting applications from professional scientists to visit Europe, North America (USA, Canada & Mexico), and North East Asia (China, Japan, Korea and Taiwan) between 1 July 2008 and 30 June 2009, to collaborate with researchers in those countries.

Proposals in any fields of natural science, basic and applied, including mathematics and engineering science, will be considered.

Applicants must propose a collaborative research project, or a specific activity, which has been developed in consultation with host scientists. Under this scheme, applicants can request travel support to access international leading-edge small to medium research facilities and equipment.

Support will not be provided for costs associated with use of these facilities or when the purpose of the visit is to attend a conference. The duration of the visits must be between 14 and 40 days.

This project is supported by the Department of Education, Science and Training’s International Science Linkages - Science Academies Programme established under the Australian Government’s innovation statement, Backing Australia’s Ability.

Information, deadlines and application forms are available on the web site: http://www.science.org.au/internat/programs.htm  

Back to Headlines>>

Announcing the GlaxoSmithKline Australia Post Graduate Support Grant

Our global quest is to improve the quality of human life by enabling people to do more, feel better and live longer. To achieve our quest, GlaxoSmithKline invests up to $35 million each year in Australian research and development - ranking us in Australia’s top 15 R&D companies (Source: see below).

Support grants for postgraduate research students

GSK Australia is pleased to offer grant awards of up to $15,000 per annum for two years to PhD or Post Doctorate students in the field of human health.

These awards will provide additional financial support to PhD or Post Doctorate research students who are currently in receipt of a research grant from a non-commercial body.

How to apply

For further information and application forms, please visit www.gsk.com.au/research  
Closing date for applications and supporting documentation is 5.00pm (AEST) Friday 27 July 2007.

Source: Australia’s 2006 R & D and Intellectual Property Scoreboard
GlaxoSmithKline is a registered trademark of the GlaxoSmithKline Group of Companies.  GlaxoSmithKline Australia Pty Ltd. 1061 Mountain Highway Boronia VIC 3155. ABN 47 100 162 481

Back to Headlines>>

Call for Proposals: Capability and Technology Demostrator Program

The Department of Defence is seeking industry proposals for participation in the  Capability and Technology Demonstrator (CTD) Program. The CTD Program assists in the improvement or support of priority Defence capability by providing Australian industry with an opportunity to demonstrate their technology, thereby informing Defence of the potential performance and technical risk associated with its implementation. Proposals should address a particular Defence capability priority and are required to demonstrate their capability potential within three years.

Some current areas of interest which applicants might wish to consider include, but are not limited to:
• Sensors/weapons applicable to urban operations
• Non-lethal weapons
• Networking of sensors, information and decision support systems
• Modelling and simulation to support acquisition, operations and planning, or network communications training
• Protection and survivability of military platforms
• Innovative weapons
• Robotics in the land environment
• Automated asset tracking
• Supersonic aerial targets
• Applications to support operational decision making
• Innovations in deployable communications
• Battlefield energy generation and storage
• Combat identification and friendly force tracking
• Counter-mine technologies
• Military platform signature management
• Navigation/communications for robotic land, sea and air vehicles
• Modular systems for multi-role military platforms

Applicants are encouraged to discuss their CTD proposals with the Capability Development Executive within Defence, and with the relevant research division of the Defence Science and Technology Organisation (DSTO). The CTD Program Office can assist prospective applicants with relevant Defence contacts and completing proposals. Proposals offering standard product lines will not normally be successful under the CTD program, unless applied in a novel manner to improve Defence capability. Proposals must originate from within Australian industry or involve substantial Australian industry participation. Project funding is expected to commence in July 2008, although some shortlisted companies may be funded for detailed proposal development or specific activities at an earlier date (conditions apply).

Send submissions by e-mail in Microsoft ® Word 2003 format, to ctd@defence.gov.au or by mail to the CTD Program Office, R1-6-A061, Russell Offices, Department of Defence, Canberra ACT 2600, by close of business, 20 July 2007.

For general information and proposal formats see the CTD website at http://www.dsto.defence.gov.au/collaboration/3743/

For further information contact Mr Andrew Arnold, Director CTD Program Office (02 6265 7927), or Dr Kathleen Smith (02 6265 7975), or email ctd@defence.gov.au.

Back to Headlines>>

AIRG Mid-Year Meeting in Canberra, 8/9th August, 2007.

Once again the AIRG will be holding a mid-year meeting in the Senate Alcove at New Parliament House in Canberra on 9th August, 2007. The theme of the meeting this year will be “A Vision for Industry in 2017 and the Role of R&D”. This will build on the themes from our recent conferences especially the recent Annual Conference where the theme was “Challenges and Opportunities for the Next Decade”. We have a range of by speakers from Industry who will present the perspective for their sectors - Resources, Biomedical, Consumer Products and Air Transport - as well as representatives from Universities and the Public sector. In addition, in the afternoon session we shall have a presentation on the CRC programme and the Research Quality Framework followed by a discussion session on policy issues affecting industry and the research sectors.

In addition, as in previous years, we are planning to hold a pre-conference dinner meeting which will be held at Rydges Capital Hill on the evening of 8th August, 2007 at which we are planning to have the Shadow Minister for Trade & Regional Development, Simon Crean, and the Shadow Minister for Industry, Innovation, Research & Development, Senator Kim Carr, as speakers.

This meeting provides a great opportunity to gain insight into the vision for the next decade from some of Australia’s leading companies and to discuss major issues with policy makers.

For further information is available on the AIRG website (www.airg.org.au)  and registration forms for these events are available from the AIRG at airg@bigpond.net.au  

Back to Headlines>>

14th IUAPPA World Congress 2007, incorporating the 18th Clean Air Society of Australia and New Zealand Conference

You are invited to attend the 14th IUAPPA World Congress 2007, which incorporates the 18th Clean Air Society of Australia and New Zealand Conference, to be held in Brisbane on 9 - 13 September, 2007.

No region of the world escapes the effects of air pollution and the flow of pollutants across national boundaries makes air pollution a global problem. The International Union of Air Pollution Prevention and Environmental Protection Associations (IUAPPA) founded in 1964, represents environmental protection specialists across the private, public and voluntary sectors in over 35 countries throughout the world.

The theme of the Congress is "Clean Air Partnerships: Coming Together for the Future" and the Congress logo grew out of the growing spirit or reconciliation with the indigenous community in Australia as well as reflecting the reconciliation between the built and the natural environment. The Congress program will focus on meaningful interactions between air quality professionals and other professional and community groups, on the consideration of partnerships between nations ( for example in the resolution of trans-boundary events) and on the management of environmental partnerships between rural and urban communities.

Outcomes from the World Congress will complement the Global Atmospheric Pollution Forum that was inaugurated at the 2004 World Congress in London. This unique event is well timed to comprehensively discuss critical environmental issues including climate change, greenhouse gases, carbon trading, indoor air toxics and transport emissions. It also provides a forum for environmental protection specialists from science, industry and government in industrialised and newly industrialising countries to exchange knowledge and focus on the challenges ahead. We invite you to participate in this exciting World Congress.

Keynote speakers include:
- Dr Alan C. Lloyd, President , International Council on Clean Transportation, USA
- Professor Andy Pitman, Co-director, Centre for Climate Change Research, University of New South Wales, Australia
- Professor Joel Schwartz, Harvard University, USA
- Professor V. Ramanthan, University of California, San Diego, USA
- Professor Ian Lowe, President, Australian Conservation Foundation, Australia

The registration brochure is available on the CASANZ website: www.casanz.org.au.  

Bookings Hotline: +61 3 9682 0244. Register online at: registration@icms.com.au.  

For further information including the program, training courses and workshops, visit the IUAPPA website: www.iuappa2007.com or contact the Congress Office: +61 7 3844 1138.

Back to Headlines>>

InnoFuture 2007

From blank sheet to breakthrough idea to market
How to turn R&D Into Innovation.
… the ultimate innovation conference!
AUGUST 28-29, MELBOURNE, PARK HYATT

Ability to compete in the global economy is an imperative for survival. The only way forward is to learn how to innovate faster, cheaper, on demand.

InnoFuture 2007, brings together the greatest masters of innovation to share the insights, experience and practical ‘how to’ tools and emerging models used by the world’s most innovative companies to develop and implement groundbreaking products, services and cultures.

Learn from the best: Tom Kelley, founder of IDEO one of the world’s top 20 most innovative companies; Frans Johansson, creator of The Medici Effect for thinking outside the boundaries, Amnon Levav, founder of Systematic Inventive Thinking, an Israeli company taking the world by storm with a new wave breakthrough innovation techniques.

Learn how to take idea to market in 90 days. How to tap into the emerging business models for sustainable competitiveness. What are the business eco-systems that create whole new industries and export opportunities for Australian R&D? How to turn your R&D efforts into money spinning opportunities? InnoFuture 2007 has the answers.

Break away from the mould of your narrow industry. Learn to find new ideas at intersections of cultures, industries, sciences and art. Take away tools to systematically innovate and start implementing innovation immediately after InnoFuture 2007. Corporate thinkers and those responsible for breaking new frontiers are invited.

Bookings and enquiries: www.innofuture.com.au.  Contact: +61 3 9596 4333 Steve Poole or Margaret Manson on +61 3 407 661 130.

Back to Headlines>>

Are you a clinician involved in NEUROSCIENCE?

The School of Enterprise, University of Melbourne, in association with the NHMRC - funded Centre of Clinical Research Excellence in Neurosciences and the Brain Research Institute, are pleased to announce that they will be holding a 4 day short course on Clinical Neuroscience Research: Neuroimaging and Disease Applications - Part 2, at the Austin Repatriation Centre on August 20, 21, 22, 24. 2007

NUMBERS ARE LIMITED, so be quick!

This course has been specifically designed for people already in clinical practice, who want to understand and interpret the existing research, or to think about the research questions before embarking on clinical research studies. Experienced clinicians who are in their first years of conducting clinical research will also benefit by consolidating their research methods and skills. In addition, this course will provide basic orientation in various clinical research methodologies applied to neuroscience for other professionals who are unfamiliar with the field of neuroscience or clinical research.

Specialist Certificate in Clinical Research (Neuroscience)

The 25 points specialist certificate is a Masters level award and is achieved by completion of the two four day subjects, Methodology and Disease Applications Part 1 & 2, with associated assessment. It provides full credit into the Masters program in Clinical Research. 

 NEED TO KNOW MORE? CHECK OUT INFORMATION AT:

www.soe.unimelb.edu.au/neuroscience  

Cost: $2,000 + GST

When: August 20, 21, 22, 24

Where: Neurosciences Building
Austin Repatriation Campus
Banksia Street Gate10)
West Heidelberg

Express your interest in this course and related courses by contacting:
• Kathy Lefevere on (03) 9496 2290 or email lefevere@unimelb.edu.au  
• Brad Atkins on (03) 9810 3185 or email b.atkins@soe.unimelb.edu.au  

Back to Headlines>>

Clinical Research Informatics

As information technology has become more powerful and sophisticated it is now possible to create data linkages and interrogate data in ways that was not even possible two years ago. The Bio21:Molecular Medicine Informatics Model (Bio21:MMIM) is an example of a recently implemented clinical research database linkage project.

"Clinical Research Informatics" is a course designed for clinical researchers who want to understand the power of the informatics tools available and maximise their opportunities for getting clinical research outcomes through application of these tools. This may include:
• Clinical researchers with their own data
• Clinical researchers or others who do not have data but have a research questions
• Clinical researchers who want to better understand what they need to do to get data, what data already exists and any possible issues
• Clinical researchers who want to be able to compare their data with other similar data for verification or other purposes, or who want access to additional data
• Clinical researchers with a background in informatics or statistics who want to update their skills and learn about contemporary practices in clinical research informatics
• Clinical research groups who have data who are interested in learning how to improve their data collection practices in order to maximise their clinical research outcomes

At the end of the course, clinical researchers will understand clinical research relational databases to the extent that they will be able to interrogate a simple relational database with provided research questions, and understand when and who they would need to collaborate with when faced with more complex research questions.

This subject is half of the Specialist Certificate in Clinical Research (Informatics & Analysis). To lean more about this award, visit our website www.soe.unimelb.edu.au/informatics  

Dates: August 13, 14, 16 & 17 2007
Cost: $2,000 per person

For further details contact Elise Strande on (03) 9810 3136 or email e.strande@soe.unimelb.edu.au  

Back to Headlines>>

IP Commercialisation Ventures & Taxation

DO YOU KNOW THE RIGHT TIME TO MOVE TO A COMPANY STRUCTURE? DO YOU KNOW HOW TO USE EMPLOYEE SHARE OPTIONS AS PART OF YOUR TOOLKIT?
DO YOU UNDERSTAND THE TAXATION ISSUES ASSOCIATED WITH THE TRANSFER OF INTELLECTUAL PROPERTY?

The School of Enterprise, University of Melbourne are pleased to announce the upcoming 1 day course on IP Commercialisation Ventures & Taxation.

Who is this course for?
This course is suitable for professionals who need to gain an up to date knowledge of the taxation issues surrounding intellectual property and the options available for different circumstances. This includes entrepreneurs, IP portfolio managers, research and development project and program managers, commercialisation and business managers, IP professionals interested in broadening their ability to advise clients strategically, SMEs and other organisations in both the public and private sectors.

What will I get out of this course?
This one day practical workshop will cover how the current tax regime works in relation to intellectual property, focusing on key impediments to commercialisation and some of the measures available to counter them. This will include preferred structures for the different “development phases” of commercialisation, providing a framework to evaluate your current position.
• Key taxation issues to be considered in commercialisation
• Why they must be addressed in order to achieve a sustainable business • The pros and cons of various structures for commercialisation with regard to taxation and the tradeoffs (such as tax versus liability)
• How to recognise when specialist assistance is required and how be prepared to engage most effectively with a specialist

Numbers are limited, so be quick!

Cost: $850 + GST per person
When: Thursday July 26th 2007, 8:45am – 5:15pm
Where: Seminar Room 0223,
Melbourne Law School
The University of Melbourne
Law School Building185 Pelham St,
Melbourne

NEED TO KNOW MORE?
Click here for more information.

Express your interest in this course or related courses by contacting;
Elise Strande on (03) 9810 3136 or email e.strande@soe.unimelb.edu.au  

Back to Headlines>>

Clinical Research in Oncology

Graduate House
220 Leicester Street
Carlton, Vic 3053
20, 21, 23 & 24 August 2007
22, 23, 24 & 26 October 2007

Overview
Clinical Research in Oncology is an enormous field and integrates the efforts of a multi-disciplinary team of medical and allied health professionals. This course has been designed to bring together this multi-disciplinary group to give them a better understanding of all types of research design conducted and surrogate endpoints derived from laboratory and functional imaging studies.

Students are presented with ethical and legal considerations relevant to clinical research in oncology as well as developing essential skills in critically appraising research presentations and publications. This will give them an understanding of the breadth of opportunity for clinical research in oncology and the various outcomes assessed by oncology clinical trials; including how and why these might differ from other disciplines. Students will also gain an appreciation of all aspects of the concept outline, and the process and requirements for successful conduct of clinical research in oncology.

Who should attend?
Oncologists in training, clinical trials nurses and people in health services, pharmaceutical industry or contract research representatives.

Presenters
• Austin Hospital
• Cancer Council Australia
• Novartis Pharmaceuticals
• Peter MacCallum Centre
• Royal Melbourne Hospital
• St Vincent’s Hospital

Registration
Closes: 20 July 2007

Fee
Specialist Certificate in Clinical Research (Oncology) - $4,000

About the program contact:
Danielle Boardman
Project Manager
T: +61 3 9810 3250
F: +61 3 9810 3149
E: d.boardman@soe.unimelb.edu.au  
W: www.soe.unimelb.edu.au/oncology  

Back to Headlines>>

Spruson&Ferguson: patent and trade mark attorneys

With over 115 years experience, Spruson&Ferguson is a leading intellectual property firm in Australia which provides a fully integrated service for the protection, commercialisation and enforcement of your intellectual property.

Spruson&Ferguson is one of the largest intellectual property firms in Australia, with a team of over 220. Our 60 plus patent and trade mark attorneys and lawyers work in specialised practice areas; Chemical/Life Sciences, Mechanical, Electrical/Information & Communications Technologies (ICT) and Trade Marks, together with Spruson&Ferguson Lawyers which provides intellectual property commercialisation, enforcement and dispute resolution services.

Spruson&Ferguson’s patent and trade mark attorneys and lawyers have extensive intellectual property and industry experience in science and engineering including pharmaceuticals, biotechnology, electronics, phototonics, transport, telecommunications, mining, publishing, consumer products, ceramics, chemistry and mechanical/medical technologies.

The depth of our industry experience is an attribute that many of our clients hold in high regard. Spruson&Ferguson is a recognised as a market leader with multinationals and many of Australia’s foremost research institutions entrusting to us to protect and assisting with the maximisation of returns on their intellectual property assets.

Our comprehensive range of services includes patents, trademarks, designs, domain names, IP audits, due diligence, dispute resolution and litigation and intellectual property commercialisation services including licensing, joint ventures and research and development collaborations.

For more information about our comprehensive range of intellectual property services, please contact one of the following relationship principals:

Chemical: Dr John McCann BSc (Hons) PhD FIPTA
Life Sciences: Dr Andrew Blattman BScAgr (Hons) PhD GDipIP FIPTA
Electrical: Robert Miller BE BLegS FIPTA
ICT: Scott Berggren BSEE MSEE LLB FIPTA
Mechanical: Greg Turner BE FIPTA
Trade Marks: Annette Freeman BA LLB (ANU) LLM (UTS)
IP Commercialisation: Rob McInnes BSc (Hons) LLB (Syd)
IP Litigation & Dispute Resolution: Simon Williams BA LLB (Syd) LLM (Lond)
Managing Principal: David Griffith BE (Hons) FIPTA

Telephone: (02) 9207 0777
Fax: (02) 9261 5486
Email mail@sprusons.com.au
Website here 

Back to Headlines>>